Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies.
Elham VosoughiJee Min LeeJames R MillerMehdi NosratiDavid R MinorRoy AbendrothJohn W LeeBrian T AndrewsLewis Z LengMax WuStanley P LeongMohammed Kashani-SabetKevin B KimPublished in: BMC cancer (2018)
These results show a significant improvement in the overall survival of patients with melanoma brain metastasis in the era of novel therapies. In addition, they suggest the activity of anti-PD-1 therapy specifically in the setting of brain metastasis.